Cannabinoids may provide a treatment option for prostate cancer that has become nonresponsive to common therapy, according to a study published in the February issue of the journal Oncology Reports, and published online this week by the National Institute of Health. According to researchers; “In the early stages, prostate cancer is androgen‑ dependent; therefore, medical …
